Are calcium channel blockers used for ventricular tachycardia?

Review

. 1989 Dec;80(6 Suppl):IV31-9.

Affiliations

• PMID: 2688983

Review

Use of calcium channel entry blockers in the treatment of cardiac arrhythmias

M Akhtar et al. Circulation. 1989 Dec.

Abstract

In clinical arrhythmias, the main therapeutic role of calcium channel entry blockers is related to their effect on the sinus and atrioventricular (AV) node. Consequently, in cardiac arrhythmias where the AV node is part of the reentry circuit, a beneficial effect of diltiazem and verapamil can be demonstrated. These include AV nodal reentry and orthodromic tachycardia in patients with Wolff-Parkinson-White syndrome. In addition, the ventricular response by the AV node during atrial tachycardias can also be controlled with these agents. A specific type of ventricular tachycardia seen in the absence of structural heart disease has also been reported to respond to intravenous and oral verapamil. Calcium channel blockers have no proven depressant effect on accessory pathway conduction. Similarly, the value of these agents in the treatment of ventricular tachycardia in association with chronic coronary artery disease and idiopathic dilated cardiomyopathy is rather limited. The use of calcium entry blockers in patients with wide QRS tachycardia, therefore, is to be discouraged unless it can be proved that supraventricular tachycardia with aberrant conduction is the underlying basis.

Similar articles

• [Electrophysiologic effects of calcium channel blockers on supraventricular tachycardia in children].

  Fujino H, Fujiseki Y, Shimada M. Fujino H, et al. J Cardiol. 1989 Mar;19(1):307-15. J Cardiol. 1989. PMID: 2810047 Japanese.

• Use of intracardiac recordings to determine the site of drug action in paroxysmal supraventricular tachycardia.

  Jackman WM, Friday KJ, Fitzgerald DM, Yeung-Lai-Wah JA, Lazzara R. Jackman WM, et al. Am J Cardiol. 1988 Dec 20;62(19):8L-19L. doi: 10.1016/0002-9149(88)90010-0. Am J Cardiol. 1988. PMID: 3059792 Review.

• [Treatment of heart arrhythmias with calcium antagonists].

  Bender F. Bender F. Z Kardiol. 1984;73 Suppl 2:101-5. Z Kardiol. 1984. PMID: 6084911 German.

• The comparative effects of diltiazem and verapamil on atrioventricular conduction and atrioventricular reentry tachycardia.

  Rowland E, McKenna WJ, Gülker H, Krikler DM. Rowland E, et al. Circ Res. 1983 Feb;52(2 Pt 2):I163-8. Circ Res. 1983. PMID: 6831649

• Use of calcium antagonists for cardiac arrhythmias.

  Singh BN, Nademanee K. Singh BN, et al. Am J Cardiol. 1987 Jan 30;59(3):153B-162B. doi: 10.1016/0002-9149(87)90096-8. Am J Cardiol. 1987. PMID: 2433930 Review.

Cited by

• Cardiac sarcomere mechanics in health and disease.

  Crocini C, Gotthardt M. Crocini C, et al. Biophys Rev. 2021 Oct 12;13(5):637-652. doi: 10.1007/s12551-021-00840-7. eCollection 2021 Oct. Biophys Rev. 2021. PMID: 34745372 Free PMC article. Review.

• Co-expression of calcium and hERG potassium channels reduces the incidence of proarrhythmic events.

  Ballouz S, Mangala MM, Perry MD, Heitmann S, Gillis JA, Hill AP, Vandenberg JI. Ballouz S, et al. Cardiovasc Res. 2021 Aug 29;117(10):2216-2227. doi: 10.1093/cvr/cvaa280. Cardiovasc Res. 2021. PMID: 33002116 Free PMC article.

• Calcium channel blocker use is associated with lower fasting serum glucose among adults with diabetes from the REGARDS study.

  Khodneva Y, Shalev A, Frank SJ, Carson AP, Safford MM. Khodneva Y, et al. Diabetes Res Clin Pract. 2016 May;115:115-21. doi: 10.1016/j.diabres.2016.01.021. Epub 2016 Jan 15. Diabetes Res Clin Pract. 2016. PMID: 26818894 Free PMC article.

• Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction.

  Su Q, Nyi TS, Li L. Su Q, et al. Cochrane Database Syst Rev. 2015 May 18;2015(5):CD009503. doi: 10.1002/14651858.CD009503.pub3. Cochrane Database Syst Rev. 2015. PMID: 25985145 Free PMC article. Review.

• Current trends in supraventricular tachycardia management.

  Sohinki D, Obel OA. Sohinki D, et al. Ochsner J. 2014 Winter;14(4):586-95. Ochsner J. 2014. PMID: 25598724 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.

• Medical

  • MedlinePlus Health Information

What is the drug of choice for ventricular tachycardia?

What is the best treatment for ventricular tachycardia?

Do calcium channel blockers treat tachycardia?

Do calcium channel blockers cause tachycardia or bradycardia?